| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2014 | WO2014003124A1 Novel amide derivative and salt thereof |
| 01/03/2014 | WO2014003116A1 Nutritional composition |
| 01/03/2014 | WO2014003098A1 Tricyclic compound |
| 01/03/2014 | WO2014003069A1 Crustacean feed |
| 01/03/2014 | WO2014002967A1 4,6-hexadecadiene-2,4-dicarboxylic acid derivative |
| 01/03/2014 | WO2014002922A1 Method for treating cancer by combined use of anti-cancer agent |
| 01/03/2014 | WO2014002851A1 Solid pharmaceutical tablet and method for producing same |
| 01/03/2014 | WO2014002599A1 Crude-drug-containing pharmaceutical composition |
| 01/03/2014 | WO2014002553A1 Aripiprazole oral pharmaceutical preparation |
| 01/03/2014 | WO2014002108A1 A core-shell nanostructure on the basis of proteins with corresponding therapeutic agents |
| 01/03/2014 | WO2014002106A1 Novel compounds for the treatment of dyslipidemia and related diseases |
| 01/03/2014 | WO2014002105A1 Compounds for the treatment of dyslipidemia and other diseases |
| 01/03/2014 | WO2014002104A1 A synergistic pharmaceutical composition useful for the treatment of lung cancer |
| 01/03/2014 | WO2014002101A1 Lim kinase inhibitors |
| 01/03/2014 | WO2014002059A1 CRYSTALLINE FORMS OF 1-(2-((1R,3S,5R)-3-(((R)-1-(3-chloro-2-fluorophenyl)ethyl)carbamoyl)-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1Hpyrazolo[3,4-c]pyridine-3-carboxamide |
| 01/03/2014 | WO2014002057A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014002054A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014002053A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014002052A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014002042A1 Injectable supersaturated acetaminophen solution for spinal administration |
| 01/03/2014 | WO2014002015A1 Pharmaceutical composition comprising dutasteride |
| 01/03/2014 | WO2014002011A1 Micronized particles of olmesartan medoxomil and pharmaceutical composition thereof |
| 01/03/2014 | WO2014001932A1 Nanogel comprising water-soluble active ingredients |
| 01/03/2014 | WO2014001924A1 Antibacterial microelement chelates and the use thereof in animal feeds |
| 01/03/2014 | WO2014001905A1 Biodegradable drug delivery for hydrophobic compositions |
| 01/03/2014 | WO2014001904A1 Biodegradable drug delivery for hydrophobic compositions |
| 01/03/2014 | WO2014001889A1 Angiotensin converting enzyme inhibitors for treating optic neuropathy or congenital optic atrophy |
| 01/03/2014 | WO2014001882A1 Composition comprising a sesterterpene and use thereof as antibiotic and antifungal adjuvant |
| 01/03/2014 | WO2014001802A1 2-aminopyrazine derivatives as csf-1 r kinase inhibitors |
| 01/03/2014 | WO2014001782A1 Antimicrobial compounds |
| 01/03/2014 | WO2014001775A1 Antimicrobial compounds |
| 01/03/2014 | WO2014001588A1 Antiparasitic composition for controlling and treating parasites of different animal species, characterised in that it combines moxidectin with vitamins a, d3 and e |
| 01/03/2014 | WO2014001562A1 Lkb1 as predictive marker of everolimus efficacy in breast cancer |
| 01/03/2014 | WO2014001554A1 Thienopyridone derivatives useful as activators of ampk |
| 01/03/2014 | WO2014001464A1 Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders |
| 01/03/2014 | WO2014001445A1 Extracorporeal perfusion apparatus |
| 01/03/2014 | WO2014001427A1 Nalmefene for reduction of alcohol consumption in specific target populations |
| 01/03/2014 | WO2014001377A1 5-azaindazole compounds and methods of use |
| 01/03/2014 | WO2014001363A1 Novel tetrazole derivatives and their use as potassium channel modulators |
| 01/03/2014 | WO2014001356A1 Method of treating lymphoma using thienotriazolodiazepine compounds |
| 01/03/2014 | WO2014001353A1 Pharmaceutical compositions and treatment of mastitis |
| 01/03/2014 | WO2014001348A1 Alkaloid derivatives of cytisine used in the treatment of diseases of the central nervous system |
| 01/03/2014 | WO2014001314A1 Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders |
| 01/03/2014 | WO2014001282A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | WO2014001281A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | WO2014001280A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | WO2014001279A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | WO2014001278A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | WO2014001247A1 N-[4-(Quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products |
| 01/03/2014 | WO2014001228A1 Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors |
| 01/03/2014 | WO2014001220A1 Method for prevention of stroke |
| 01/03/2014 | WO2014001183A1 Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction |
| 01/03/2014 | WO2014001120A1 Isothiazole derivatives as insecticidal compounds |
| 01/03/2014 | WO2014001092A1 Antimicrobial composition |
| 01/03/2014 | WO2014001059A1 Antimicrobial composition |
| 01/03/2014 | WO2014001057A1 Antimicrobial composition |
| 01/03/2014 | WO2014001056A1 Antimicrobial composition |
| 01/03/2014 | WO2014001052A1 Antimicrobial composition |
| 01/03/2014 | WO2014000719A1 Novel pharmaceutical solid forms of (1s,2s,3r,5s)-3-[7-[(1r,2s)-2-(3,4difluorophenyl)cyclopropylamino]-5-(propylthio)-3h-[1,2,3]triazolo[4,5-d]pyrimidin-3yl]-5-(2-hydroxyethoxy)cyclopentane-l,2-diol |
| 01/03/2014 | WO2014000713A1 NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS |
| 01/03/2014 | WO2014000694A1 Phendioxin heterocycle derivative |
| 01/03/2014 | WO2014000686A1 Pyrimidobenzoazepine compound and use thereof as antitumour drug |
| 01/03/2014 | WO2014000629A1 Hexahydropentaleno derivatives, preparation method and use in medicine thereof |
| 01/03/2014 | WO2014000586A1 Phenanthroindolizidine alkaloid derivates and salt thereof as well as preparation, plant-virus resisting activity, and anti-cancer activity of phenanthroindolizidine alkaloid derivates and salt thereof |
| 01/03/2014 | WO2014000541A1 Acyclic nucleotide analogue, preparation method therefor, and application thereof |
| 01/03/2014 | WO2014000418A1 Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agents |
| 01/03/2014 | WO2014000313A1 Pharmaceutical composition for treating aids, preparation method therefor and use thereof |
| 01/03/2014 | WO2014000178A1 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| 01/03/2014 | WO2014000144A1 Compound preparation of cefotaxime sodium and sulbactam sodium as well as preparation method and application thereof |
| 01/03/2014 | WO2014000077A1 Method for obtaining high concentrations of the chemical constituent trans-pinocarvyl acetate by hydrodistillation of the aerial parts of microlicia graveolens and obtaining nano-emulsified formulations |
| 01/03/2014 | WO2014000058A1 Method of treating glucose metabolism disorders |
| 01/03/2014 | WO2014000033A1 Polymer-nsaid conjugate |
| 01/03/2014 | WO2014000032A1 Phenyl amino pyrimidine bicyclic compounds and uses thereof |
| 01/03/2014 | WO2014000027A1 Prevention and treatment of haematological conditions |
| 01/03/2014 | WO2013171766A3 Saxagliptin solid dispersion |
| 01/03/2014 | WO2013166413A3 Compositions and methods for increasing neurotrophic peptides |
| 01/03/2014 | WO2013166004A3 Organic compositions to treat kras-related diseases |
| 01/03/2014 | WO2013160810A3 Novel betulinic acid derivatives as hiv inhibitors |
| 01/03/2014 | WO2013160317A3 Crhr1 antagonists for use in the treatment of patients having crh overactivity |
| 01/03/2014 | WO2013156861A3 Methods and compounds for treating proliferative disorders and viral infections |
| 01/03/2014 | WO2013155204A3 Compositions and methods for inhibiting expression of the alas1 gene |
| 01/03/2014 | WO2013142628A4 Antibiotic compounds and compositions, and methods for identification thereof |
| 01/03/2014 | WO2013140319A9 Crystalline form of a succinate salt |
| 01/03/2014 | WO2013000651A8 Fluorinated arylalkylaminocarboxamide derivatives |
| 01/03/2014 | WO2012175085A8 Tobacco chewing gum formulation |
| 01/03/2014 | WO2012170930A9 Lipid nanoparticle compositions and methods for mrna delivery |
| 01/03/2014 | WO2012145737A8 Fatty acid amide hydrolase inhibitors for treating pain |
| 01/03/2014 | WO2012112964A3 PYRIDO[4,3-b]INDOLE AND PYRIDO[3,4-b]INDOLE DERIVATIVES AND METHODS OF USE |
| 01/03/2014 | WO2009158026A9 Hydrazonamide compounds that modulate hsp90 activity |
| 01/03/2014 | CA2878267A1 Methods of treating pediatric metabolic syndrome |
| 01/03/2014 | CA2878049A1 Novel fused pyridine derivatives useful as c-met tyrosine kinase inhibitors |
| 01/03/2014 | CA2878011A1 Fenofibrate formulation |
| 01/03/2014 | CA2877998A1 Antibacterial microelement chelates and the use thereof in animal feeds |
| 01/03/2014 | CA2877953A1 Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function |
| 01/03/2014 | CA2877941A1 Compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 01/03/2014 | CA2877923A1 Phenyl amino pyrimidine bicyclic compounds and uses thereof |
| 01/03/2014 | CA2877909A1 Stable formulations for parenteral injection of small molecule drugs |
| 01/03/2014 | CA2877905A1 Modulation of ube3a-ats expression |
| 01/03/2014 | CA2877901A1 Fenofibrate formulation |
| 01/03/2014 | CA2877884A1 Plant parts and extracts having anticoccidial activity |